Literature DB >> 29851250

Human Induced Pluripotent Stem Cell Production and Expansion from Blood using a Non-Integrating Viral Reprogramming Vector.

Arun Sharma1, Michael Mücke1,2,3, Christine E Seidman1,4.   

Abstract

We describe a method to transform blood lymphocytes into human-induced pluripotent stem cells by delivering four transcription factors with a non-integrative virus. Using human peripheral blood mononuclear cells (PBMCs) as the source cell type for hiPSC reprogramming is advantageous since blood samples are rapidly and safely obtained from nearly-all subjects. Reprogramming factors needed to make hiPSCs are introduced by infecting the PBMCs with non-integrating Sendai virus vectors. Reprogrammed cells can subsequently be quickly expanded for downstream use. In this unit, we present current protocols for the isolation of PBMCs from a small sample of human blood and subsequent viral reprogramming and expansion of PBMCs into hiPSCs. © 2018 by John Wiley & Sons, Inc.
Copyright © 2018 John Wiley & Sons, Inc.

Entities:  

Keywords:  PBMC; Sendai virus; cell fate; iPSCs; pluripotent stem cells; reprogramming

Mesh:

Year:  2018        PMID: 29851250      PMCID: PMC5986089          DOI: 10.1002/cpmb.58

Source DB:  PubMed          Journal:  Curr Protoc Mol Biol        ISSN: 1934-3647


  29 in total

1.  Hypoxia enhances the generation of induced pluripotent stem cells.

Authors:  Yoshinori Yoshida; Kazutoshi Takahashi; Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Cell Stem Cell       Date:  2009-08-27       Impact factor: 24.633

2.  Molecular analyses of human induced pluripotent stem cells and embryonic stem cells.

Authors:  Mark H Chin; Matteo Pellegrini; Kathrin Plath; William E Lowry
Journal:  Cell Stem Cell       Date:  2010-08-06       Impact factor: 24.633

3.  High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells.

Authors:  Arun Sharma; Paul W Burridge; Wesley L McKeithan; Ricardo Serrano; Praveen Shukla; Nazish Sayed; Jared M Churko; Tomoya Kitani; Haodi Wu; Alexandra Holmström; Elena Matsa; Yuan Zhang; Anusha Kumar; Alice C Fan; Juan C Del Álamo; Sean M Wu; Javid J Moslehi; Mark Mercola; Joseph C Wu
Journal:  Sci Transl Med       Date:  2017-02-15       Impact factor: 17.956

4.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

5.  Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform.

Authors:  Arun Sharma; Caleb Marceau; Ryoko Hamaguchi; Paul W Burridge; Kuppusamy Rajarajan; Jared M Churko; Haodi Wu; Karim I Sallam; Elena Matsa; Anthony C Sturzu; Yonglu Che; Antje Ebert; Sebastian Diecke; Ping Liang; Kristy Red-Horse; Jan E Carette; Sean M Wu; Joseph C Wu
Journal:  Circ Res       Date:  2014-07-11       Impact factor: 17.367

Review 6.  Assessing iPSC reprogramming methods for their suitability in translational medicine.

Authors:  Mahendra S Rao; Nasir Malik
Journal:  J Cell Biochem       Date:  2012-10       Impact factor: 4.429

7.  Partial Reprogramming of Pluripotent Stem Cell-Derived Cardiomyocytes into Neurons.

Authors:  Wenpo Chuang; Arun Sharma; Praveen Shukla; Guang Li; Moritz Mall; Kuppusamy Rajarajan; Oscar J Abilez; Ryoko Hamaguchi; Joseph C Wu; Marius Wernig; Sean M Wu
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

Review 8.  Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screening.

Authors:  Arun Sharma; Joseph C Wu; Sean M Wu
Journal:  Stem Cell Res Ther       Date:  2013-12-24       Impact factor: 6.832

9.  Chemically defined generation of human cardiomyocytes.

Authors:  Paul W Burridge; Elena Matsa; Praveen Shukla; Ziliang C Lin; Jared M Churko; Antje D Ebert; Feng Lan; Sebastian Diecke; Bruno Huber; Nicholas M Mordwinkin; Jordan R Plews; Oscar J Abilez; Bianxiao Cui; Joseph D Gold; Joseph C Wu
Journal:  Nat Methods       Date:  2014-06-15       Impact factor: 28.547

10.  Human finger-prick induced pluripotent stem cells facilitate the development of stem cell banking.

Authors:  Hong-Kee Tan; Cheng-Xu Delon Toh; Dongrui Ma; Binxia Yang; Tong Ming Liu; Jun Lu; Chee-Wai Wong; Tze-Kai Tan; Hu Li; Christopher Syn; Eng-Lee Tan; Bing Lim; Yoon-Pin Lim; Stuart A Cook; Yuin-Han Loh
Journal:  Stem Cells Transl Med       Date:  2014-03-19       Impact factor: 6.940

View more
  2 in total

1.  Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vector.

Authors:  Takashi Okumura; Yumi Horie; Chen-Yi Lai; Huan-Ting Lin; Hirofumi Shoda; Bunki Natsumoto; Keishi Fujio; Eri Kumaki; Tsubasa Okano; Shintaro Ono; Kay Tanita; Tomohiro Morio; Hirokazu Kanegane; Hisanori Hasegawa; Fumitaka Mizoguchi; Kimito Kawahata; Hitoshi Kohsaka; Hiroshi Moritake; Hiroyuki Nunoi; Hironori Waki; Shin-Ichi Tamaru; Takayoshi Sasako; Toshimasa Yamauchi; Takashi Kadowaki; Hiroyuki Tanaka; Sachiko Kitanaka; Ken Nishimura; Manami Ohtaka; Mahito Nakanishi; Makoto Otsu
Journal:  Stem Cell Res Ther       Date:  2019-06-24       Impact factor: 6.832

2.  The Use of Induced Pluripotent Stem Cells as a Model for Developmental Eye Disorders.

Authors:  Jonathan Eintracht; Maria Toms; Mariya Moosajee
Journal:  Front Cell Neurosci       Date:  2020-08-20       Impact factor: 5.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.